GSK Pulls Imus Ads...BUT, Only Until "Media Standards" Are Met

Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.

We accept advertising relevant to the interests of our members.
For more information, see:

Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com

My Humble Opinion	Other People's Opinion
A "Must Read" Blog for Insiders. -- Wall Street Journal	A bi-weekly podcast. Listen and call-in live online or download to your iPod!

| Also see Pharma Marketing News OpEd Pieces |

GSK Pulls Imus Ads...BUT, Only Until "Media Standards" Are Met

Posted: April 11, 2007

Within hours of my call for Glaxo to pull its Imus ads (see "Glaxo, Pull Your Imus Ads"), I learn that GSK has heeded my advice.

Unfortunately, the action was not accompanied by any press release or strong statement as to the values that GSK supports other than to say "The bottom line is that we have suspended our advertising with MSNBC until we can determine that we can have a level of confidence that our media standards are being adhered to."

Could GSK have made a point of supporting the young Rutgers' women who were attacked by Imus and thereby enhanced their reputation among all young women? Could such a public statement help GSK when it comes time to reach out to young women before and after its HPV vaccine (Cervarix) comes to market?

For more on this, see today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

| Return to Pharma Marketing Blog Topics |

Special Supplement
Direct-to-Consumer Advertising
Volume Two: DTC in the New Era

DTC advertising is set for major changes in light of public criticism, but also in reaction to the changing reality of the marketplace where there is less need for a one size fits all solution. DTC must evolve and marketers must pay more attention to measuring and improving its effectiveness. Otherwise, billions of dollars will continue to be wasted. This volume is devoted to DTC best practices with a focus on techniques for improving DTC efficacy and return on investment, which is generally considered to be declining.

TABLE OF CONTENTS

Order both Volume One and Volume Two and SAVE! (Click Here)

Order and pay for Volume Two now using your credit card.

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form